114  Total SME IPOs listed in 2025

5,174.44 Crs.  Total funds raised in 2025

79  SME IPOs listed with Gain in 2025

35  SME IPOs listed with loss in 2025

114  Total SME IPOs listed in 2025

5,174.44 Crs.  Total funds raised in 2025

79  SME IPOs listed with Gain in 2025

35  SME IPOs listed with loss in 2025

114  Total SME IPOs listed in 2025

5,174.44 Crs.  Total funds raised in 2025

79  SME IPOs listed with Gain in 2025

35  SME IPOs listed with loss in 2025

114  Total SME IPOs listed in 2025

5174.44 Crs.  Total funds raised in 2,025.00

79  SME IPOs listed with Gain in 2025

35  SME IPOs listed with loss in 2025

MK Proteins Limited IPO Analysis

MK Proteins IPO is a Fixed Price listing on NSE EMERGE exchange, with an ipo size of ₹ 10.23 Cr. The company is based in Ambala and caters to Agro - Food Products sector. Sarthi Capital Advisors is the merchant banker of MK Proteins IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 7th March 2017.

MK Proteins IPO posted revenues of ₹ 147.91 Cr. and PAT of ₹ 0.55 Cr. in FY17 on annualised basis.

IPO Key Highlights

*At the time of IPO, on Annualised Basis
  • Revenue: ₹ 147.91 Cr.
            EBITDA: ₹ 4.00 Cr.
            PAT: ₹ 0.55 Cr.
  • EBITDA Margin: 2.70 %
            Pat Margin: 0.37 %
  • Net Worth: ₹ 3.67 Cr.
  • Market Capitalisation: [●]
  • P/E: 53.00 times
  • P/BV: [●]
  • EV/EBITDA: 4.77 times
Nature of IPO : SME
Exchange : NSE EMERGE
IPO Type : Fixed Price

MK Proteins IPO Financial Performance (Restated)

Financial results of MK Proteins IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.

Amount in ₹ crores
Financials Dec-16 FY16 FY15 FY14
Balance Sheet
Assets 42.45 38.78 35.05 32.04
Net Worth 3.67 3.26 2.53 1.70
Total Debt 19.10 25.87 19.60 27.82
Profit & Loss
Revenue
Revenue on annualised basis
110.93
147.91
144.75 123.23 121.73
EBITDA
EBITDA on annualised basis
3.00
4.00
4.27 4.16 2.80
PAT
PAT on annualised basis
0.41
0.55
0.72 0.83 0.49
Financials
31-Dec-16
FY16
FY15
FY14
Balance Sheet
Assets
42.45
38.78
35.05
32.04

Net Worth
3.67
3.26
2.53
1.70

Total Debt
19.10
25.87
19.60
27.82

Profit & Loss
Revenue
Revenue on annualised basis
110.93
147.91
144.75
123.23
121.73

EBITDA
EBITDA on annualised basis
3.00
4.00
4.27
4.16
2.80

PAT
PAT on annualised basis
0.41
0.55
0.72
0.83
0.49

Notes:
1) Total debt incluides long-term borrowings and short-term borrowings.
2) Revenue means the Revenue from Operations as appearing in the Restated Financial Statements.

MK Proteins IPO Key performance Indicators (KPI)

MK Proteins IPO PAT Margin is 0.37 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows MK Proteins IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.

Particulars Dec-16 FY16 FY15 FY14
EBITDA Margin (%) 2.70 2.95 3.38 2.30
PAT Margin (%) 0.37 0.50 0.67 0.40
EPS (₹) 1.53 2.67 3.09 1.82
ROE (%) 11.17 22.09 32.81 28.82
ROCE (%) [●] [●] [●] [●]
ROA (%) 0.97 1.86 2.37 1.53
Debt to Equity 5.20 7.94 7.75 16.36
Particulars
31-Dec-16
FY16
FY15
FY14

EBITDA Margin (%)
2.70
2.95
3.38
2.30

PAT Margin (%)
0.37
0.50
0.67
0.40

EPS (₹)
1.53
2.67
3.09
1.82

ROE (%)
11.17
22.09
32.81
28.82

ROCE (%)
[●]
[●]
[●]
[●]

ROA (%)
0.97
1.86
2.37
1.53

Debt to Equity (x)  
5.20
7.94
7.75
16.36

Notes:
1) The EPS represents post-bonus basic EPS.
2) Return on Equity is ratio of Profit after Tax and Total Equity.
3) Return on Assets is ratio of Profit after Tax and Total Assets.
4) Debt to Equity is ratio of Total borrowings and Total Equity.

MK Proteins IPO Valuation Metrics

The market Capitalisation of MK Proteins IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.

Key Metrics (at the time of IPO)


Market Capitalisation (₹ Cr.):
[●]

Enterprise Value (EV) (₹ Cr.):
[●]

EV/EBITDA (times) :
[●]

PE Multiple (times) :
53.00

P/B (times) :
[●]

NAV (₹) :
[●]

Notes:
1) The Enterprise Value is calculated as Market Cap. + Total Debt - Cash and Cash Equivalents.
2) Price to Book multiple is calculated as the ratio of Market Cap. and Net Worth post IPO proceeds.

What are the key financial metrics in MK Proteins prospectus?

The MK Proteins IPO prospectus highlights an Return on Equity (ROE) of 11.17 % , Return on Assets (ROA) of 0.97 %, and an EBITDA Margin of 2.70 %, showcasing financial performance.

How do profitability ratios impact the evaluation of MK Proteins IPO?

Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows MK Proteins IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.

What is the market capitalisation for MK Proteins IPO ?

The post-IPO market capitalisation of MK Proteins IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.

What is the PE Multiple of MK Proteins IPO?

The MK Proteins IPO has a Price-to-Earnings (PE) ratio of 53.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.

What is the Revenue of MK Proteins IPO?

MK Proteins IPO reported revenue of ₹ 147.97 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from MK Proteins IPO provide insights into sales growth, market demand, and business scalability.

What is the EBITDA of MK Proteins IPO?

MK Proteins recorded an EBITDA of ₹ 4.00 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.

What is the PAT of MK Proteins IPO?

MK Proteins Profit After Tax (PAT) is ₹ 0.55 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions

IPO Key Highlights

*At the time of IPO, on Annualised Basis
  • Revenue: ₹ 147.91 Cr.
            EBITDA: ₹ 4.00 Cr.
            PAT: ₹ 0.55 Cr.
  • EBITDA Margin: 2.70 %
            Pat Margin: 0.37 %
  • Net Worth: ₹ 3.67 Cr.
  • Market Capitalisation: [●]
  • P/E: 53.00 times
  • P/BV: [●]
  • EV/EBITDA: [●]

Revenue

(As Annualised)

EBITDA

(As Annualised)

PAT

(As Annualised)
Thinking of
Listing Your Business through
SME IPO?
We can Help!
Contact Us Today

Recent IPO List

Spunweb Nonwoven Limited

  Textiles

  Rajkot


CFF Fluid Control Limited - FPO

  Defence

  Raigarh


Asston Pharmaceuticals Limited

  Pharmaceutical

  Mumbai


GLEN Industries Limited

  Packaging & Disposables

  Kolkata


Smarten Power Systems Limited

  Solar

  New Delhi


Recent IPO List

Spunweb Nonwoven Limited

  Textiles

  Rajkot


CFF Fluid Control Limited - FPO

  Defence

  Raigarh


Asston Pharmaceuticals Limited

  Pharmaceutical

  Mumbai


GLEN Industries Limited

  Packaging & Disposables

  Kolkata


Smarten Power Systems Limited

  Solar

  New Delhi


Read more details of this IPO

Peer Companies Of This Sector

FAQs

MK Proteins operates in Agro - Food Products and Manufacturing And Trading Organization Having Its Production Refining Plant Of Edible Oils. The Issue is listed on NSE EMERGE in Apr, 2017. MK Proteins IPO size was 10.23 with Issue price of 70.00 .

MK Proteins IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

MK Proteins IPO listed at a listing price of 72.00 against the offer price of 70.00.

The current market price of MK Proteins is 7.27.

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency